Carl P. Sparrow
Merck Research Laboratories
Rahway
USA
Name/email consistency: high
- A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. Sparrow, C.P., Baffic, J., Lam, M.H., Lund, E.G., Adams, A.D., Fu, X., Hayes, N., Jones, A.B., Macnaul, K.L., Ondeyka, J., Singh, S., Wang, J., Zhou, G., Moller, D.E., Wright, S.D., Menke, J.G. J. Biol. Chem. (2002)
- Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Sparrow, C.P., Burton, C.A., Hernandez, M., Mundt, S., Hassing, H., Patel, S., Rosa, R., Hermanowski-Vosatka, A., Wang, P.R., Zhang, D., Peterson, L., Detmers, P.A., Chao, Y.S., Wright, S.D. Arterioscler. Thromb. Vasc. Biol. (2001)